Lina Khan, FTC chair (Graeme Jennings/Pool via AP Images)
July 2, 2021 09:52 AM EDT
Pharma

Phar­ma in the crosshairs: How the FTC is ex­pand­ing its an­titrust pow­ers un­der its new chair

Zachary Brennan

Senior Editor

Less than a month since her Sen­ate con­fir­ma­tion, the new, young and staunch­ly pro­gres­sive Fed­er­al Trade Com­mis­sion chair Lina Khan is ready to up the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

TIG­IT grave­yard ex­pands as GSK drops late-stage as­set with iTeos

Bay­er starts 2025 by cut­ting 2,000 jobs as it homes in on year-end re­haul tar­get

Some gener­ics, biosim­i­lar drug­mak­ers say they can with­stand tar­iff im­pact

Unit­ed­Health Group CEO An­drew Wit­ty steps down

Up­dat­ed: To spin off or not to spin off? Gala­pa­gos backpedals on sep­a­ra­tion plans, CEO Paul Stof­fels ex­its ear­ly

Arc­turus to pri­or­i­tize mR­NA ther­a­peu­tics in bid to boost rare dis­ease pro­grams

A service from the Financial Times